The goal of this study was to evaluate the efficacy of a cognitive-behavioral treatment package for comorbid generalized anxiety disorder (GAD) and panic disorder with agoraphobia (PDA). A single-case, multiple-baseline, across-subjects design was used with 3 primary GAD patients with secondary PDA. The efficacy of the treatment was evaluated with a structured interview, a battery of self-report questionnaires, and daily self-monitoring booklets. Results are promising: At posttreatment, 2 out of 3 participants achieved high endstate functioning and maintained this level at 3-, 6-, and 12-month follow-ups. The 3rd participant also improved but achieved moderate endstate functioning. The strengths and limitations of the treatment are discussed.
American Psychiatric Association. (1987). Diagnostic and statistical manual of mental disorders (3rd ed., rev.). Washington, DC: Author.
2.
American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
3.
Baldwin, D. S. (1998). Depression and panic: Comorbidity. European Psychiatry, 13(Suppl. 2), 65-70.
4.
Barlow, D. H., & Hersen, M. (1984). Single case experimental design: Strategies for studying behavior change (2nd ed.). New York: Pergamon.
5.
Beck, A. T., Rush, A. J., Shaw, B. F., & Emery, G. (1979). Cognitive therapy of depression.New York: Guilford.
6.
Birchall, H., Brandon, S., & Taub, N. (2000). Panic in general practice population: Prevalence, psychiatric comorbidity and associated disability. Social Psychiatry and Psychiatric Epidemiology, 35, 235-241.
7.
Boivin, I., & Marchand, A. (1996). Évaluation structurée pour les troubles anxieux pour le DSM-IV [Anxiety disorders interview schedule for DSM-IV]. Unpublished manuscript, Université du Québec à Montréal, Department of Psychology.
8.
Borkovec, T. D., Abel,J. L.,& Newman,H. (1995). Effects ofpsychotherapy oncomorbidconditions in generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 63, 479-483.
9.
Bourque, P., & Beaudette, D. (1982). Étude psychométrique du questionnaire de dépression de Beck auprès d'un échantillon d'étudiants universitaires francophones [Psychometric study of the Beck Depression Inventory in a French university student sample]. Revue Canadienne des Sciences du Comportement, 14, 211-218.
10.
Brawman-Mintzer, O., & Lydiard,B. R. (1996). Generalizedanxietydisorder:Issues in epidemiology. Journal of Clinical Psychiatry, 57(Suppl. 7), 3-8.
11.
Brown, C., & Schulberg, H. C. (1997). Depression and anxiety disorders: Diagnosis and treatment in primarycare practice. In S. J. Gallant, G. P. Keita, & R. Royak-Schaler(Eds.), Health care for women: Psychological, social, and behavioral influences (pp. 237-256). Washington, DC: American Psychological Association.
12.
Brown, T. A., Antony, M. M., & Barlow, D. H. (1995). Diagnostic comorbidityin panic disorder: Effect on treatment outcomeand course of comorbiditydiagnoses following treatment. Journal of Consulting and Clinical Psychology, 63, 408-418.
13.
Brown, T. A., & Barlow, D. H. (1992). Comorbidity among anxiety disorders: Implications for treatment and DSM-IV. Journal of Consulting and Clinical Psychology, 60, 835-844.
14.
Brown, T. A., & Barlow, D. H. (2002). Classification of anxiety and mood disorders. In D. H. Barlow (Ed.), Anxiety and its disorders (2nd ed., pp. 292-327). New York: Guilford.
15.
Chambless, D. L., Caputo, G. C., Bright, P., & Gallagher, R. (1984). Assessment of fear in agoraphobics: The body sensation questionnaire and the agoraphobic cognitions questionnaire. Journal of Consulting and Clinical Psychology, 52, 1090-1097.
16.
Chambless, D. L., Caputo, G. C., Jasin, S. E., Gracely, E. J., & Williams, C. (1985). The mobility inventory for agoraphobia. Behavior Research and Therapy, 23, 35-44.
17.
Craske, M. G., & Barlow, D. H. (1993). Panic disorder and agoraphobia. In D. H. Barlow (Ed.), Clinical handbook of psychological disorders: A step-by-step treatment manual (2nd ed., pp. 1-47). New York: Guilford.
18.
Curry, J. F., & Murphy, L. B. (1995). Comorbidityof anxiety disorders. In J. S. March (Ed.), Anxiety disorders in children and adolescents (pp. 301-317). New York: Guilford.
19.
Di Nardo, P. A., & Barlow, D. H. (1990). Syndrome and symptom co-occurrence in the anxiety disorders. In J. D. Maser & C. R. Cloninger (Eds.), Comorbidity of mood and anxiety disorders (pp. 205-230). Washington, DC: American Psychiatric Press.
20.
Di Nardo, P. A., Brown, T. A., & Barlow, D. H. (1994). Anxiety disorders interview schedule for DSM-IV. Unpublished manuscript, University of Albany, Phobia and Anxiety Disorders Clinic Center for Stress and Anxiety Disorders, New York.
21.
Dugas, M. J., Freeston, M. H., & Ladouceur, R. (1997). Intolerance of uncertainty and problem orientation in worry. Cognitive Therapy and Research, 21, 593-606.
22.
Dugas, M. J., Freeston, M. H., Provencher, M. D., Lachance, S., Ladouceur, R., & Gosselin, P. (2001). Le questionnaire sur l'inquiétude et l'anxiété: Validation dans des échantillons non cliniques et cliniques [The Worry and Anxiety Questionnaire: Validation in non-clinical and clinical samples]. Journal de Thérapie Comportementale et Cognitive, 11, 31-36.
23.
Dugas, M. J., & Ladouceur, R. (2000). Treatment of GAD: Targeting intolerance of uncertainty in two types of worry. Behavior Modification, 24, 635-657.
24.
Durham, R. C., Allan, T., & Hackett, C. A. (1997). On predicting improvement and relapse in generalized anxiety disorder following psychotherapy. British Journal of Clinical Psychology, 36, 101-119.
25.
First, M. B., Spitzer, R. L., Gibbon, M., Williams, J. B. W., & Benjamin, L. (1990). Structured clinical interview for DSM-IV Axis II Personality disorders (SCID-II). Unpublished manuscript, New York State Psychiatric Institute, Biometrics Research Department.
26.
Freeston, M. H., Rhéaume, J., Letarte, H., Dugas, M. J., & Ladouceur, R. (1994). Why do people worry?Personality and Individual Differences, 17, 791-802.
27.
Fyer, A. J., Liebowitz, M. R., & Klein, D. F. (1990). Treatments, trials, comorbidity, and syndromal complexity. In J. D. Maser & C. R. Cloninger (Eds.), Comorbidity of mood and anxiety disorders (pp. 669-681). Washington, DC: American Psychiatric Press.
28.
Gauthier, J. G., & Bouchard, S. (1993). Adaptation canadienne-française de la forme révisée de State-Trait Anxiety Inventory de Spielberger [A French-Canadian adaptation of Spielberger's State-Trait Anxiety Inventory, revised version]. Revue Canadienne des Sciences du Comportement, 25, 559-578.
29.
Goisman, R. M., Goldenberg, I., Vasile, R. G., & Keller, M. B. (1995). Comorbidity of anxiety disorders in a multicenter anxiety study. Comprehensive Psychiatry, 36, 303-311.
30.
Goldenberg, I. M., White, K., Yonkers, K., Reich, J., Warshaw, M. G., Goisman, R. M., et al. (1996). The infrequency of “pure culture” diagnosis among the anxiety disorders. Journal of Clinical Psychiatry, 57, 528-533.
31.
Gosselin, P., Dugas, M. J., Ladouceur, R., & Freeston, M. H. (2001). Evaluation des inquiétudes: Validation d'une traduction française du Penn State Worry Questionnaire [Worry assessment: Validation of a French translation of the Penn State Worry Questionnaire]. L'Encéphale, 25, 475-484.
32.
Health Canada. (1996). Les troubles anxieux et leur traitement: Analyse critique de la littérature sur les traitements fondés sur les preuves [Anxiety disorders and their treatment: A critical review of the evidence-basedliterature](CAT. H39-388/2-1996F).Ottawa, Ontario,Canada: Health Canada Publications Program.
33.
Jacobson, N. S., & Truax, P. (1992). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. In A. E. Kazdin (Ed.), Methodological issues and strategies in clinical research (pp. 631-648). Washington, DC: American Psychological Association.
34.
Keller, M. B., Yonkers, K. A., Warshaw, M. G., Pratt, L. A., Gollan, J. K., Massion, A. O., et al. (1994). Remission and relapse in subjects with panic disorder and panic with agoraphobia:A prospective short-interval naturalistic follow-up. The Journal of Nervous and Mental Disease, 182, 290-296.
35.
Kessler, R. C., McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eshleman, S., et al. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the National Comorbidity Survey. Archives of General Psychiatry, 51, 8-19.
36.
Labrecque, J., Leblanc, G., Kirouac, C., Stephenson, R., & Marchand, A. (2001, October). Validation d'un questionnaire mesurant la qualité de vie auprès d'un échantillon d'étudiants[Validation of a questionnaire measuring quality of life in a student sample]. Poster session presented at the XXIVe congrès de la Société Québécoise de Recherche en Psychologie, Chicoutimi, Québec, Canada.
37.
Labrecque, J., Marchand, A., Dugas, M. J., & Letarte, A. (2003). Efficacy of cognitive-behavioral therapy for comorbid panic disorder with agoraphobia and generalized anxiety disorder. Manuscript submitted for publication.
38.
Labrecque, J., Marchand, L., Kirouac, C., Leblanc, G., & Marchand, A. (2002, May). Validation de l'Index de sensibilité à l'anxiété auprès d'une population francophone du Québec [Validation of the Anxiety Sensitivity Index in the Francophone population in Québec]. Poster session presented at the 4e congrès de l'Association/Troubles anxieux du Québec, Québec, Canada.
39.
Ladouceur, R., & Bégin, G. (1980). Protocoles de recherche en sciences appliquées et fondamentales [Research protocols in the applied and fundamental sciences]. St. Hyacinthe, Québec: Edisem.
40.
Ladouceur, R., Dugas, M. J., Freeston, M. H., Léger, E., Gagnon, F., & Thibodeau, N. (2000). Efficacy of a new cognitive-behavioral treatment for generalized anxiety disorder: Evaluation in a controlled clinical trial. Journal of Consulting and Clinical Psychology, 68, 957-964.
41.
Ladouceur, R., Freeston, M. H., Dumont, J., Letarte, H., Rhéaume, J., Gagnon, F., et al. (1992). Penn State Worry Questionnaire: Validity and reliability of a French translation. Canadian Psychology, 33, 236-236.
42.
Ladouceur, R., Talbot, F., & Dugas, M. J. (1997). Behavioral expression of intolerance of uncertainty in worry. Behavior Modification, 21, 355-371.
43.
Lapalme, M., & Hodgins, S. (1998). Entrevue clinique structurée pour le DSM-IV Axe II: Troubles de la personnalité [Structured clinical interview for DSM-IV Axis II: Personality disorders]. Unpublished manuscript, Université de Montréal, Département de Psychologie, Groupe de Recherche sur le Développement des Troubles Affectifs, Québec, Canada.
44.
Lecrubier, Y., & Weiller, E. (1997). Comorbidities in social phobia. International Clinical Psychopharmacology, 12(Suppl. 6), 17-21.
45.
Léger, E., Freeston, M. H., Dugas, M. J., & Ladouceur, R. (1998). Questionnaire sur la qualité de vie [Quality of life questionnaire]. Unpublished manuscript, Université Laval, École de Psychologie, Laboratoire de Thérapies Behaviorales, Québec, Canada.
46.
Léger, E., Freeston, M. H., & Ladouceur, R. (1998). Treatment of GAD in a person with multiple sclerosis. Behavioral and Cognitive Psychotherapy, 26, 261-269.
47.
Marchand, A., & Letarte, A. (1993). La peur d'avoir peur [The fear of fear]. Montréal, Canada: Stanké.
48.
Marshall, J. R. (1996). Comorbidity and its effects on panic disorder. Bulletin of the Menninger Clinic, 60, 39-53.
49.
Massion, A. O., Warshaw, M. G., & Keller, M. B. (1993). Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. American Journal of Psychiatry, 150, 600-607.
50.
Meyer, T. J., Miller, M. L., Metzger, R. L., & Borkovec, T. D. (1990). Development and validationofthePennState WorryQuestionnaire. BehaviorResearch andTherapy, 28, 487-495.
51.
Mitchell, G., & Pollard, C. A. (1999). Clinical management of comorbidity in anxiety disorder patients. Crisis Intervention, 5, 109-118.
52.
Newman, D. L., Moffit, T. E., Caspi, A., & Silva, P. A. (1998). Comorbid mental disorders: Implications for treatment and sample selection. Journal of Abnormal Psychology, 107, 305-311.
53.
Noyes, R., Jr. (2001). Comorbidity in generalized anxiety disorder. The Psychiatric Clinics of North America, 24, 41-55.
54.
Provencher, M. (2001). Le trouble d'anxiété généralisée: Impact d'un traitement cognitifcomportemental individualisé et de la comorbidité sur l'efficacité du traitement [Generalized Anxiety Disorder: Impact of an individualized cognitive-behavioral treatment and comorbidity on treatment efficacy]. Unpublished doctoral dissertation, Université Laval, Québec, Canada.
55.
Provencher, M. D., Ladouceur, R., & Dugas, M. J. (2002). Targeting two types of worry in the treatment of generalized anxiety disorder: A case replication series. Manuscript submitted for publication.
56.
Reiss, S., Peterson, R. A., Gursky, D. M, & McNally, R. J. (1986). Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behavior Research and Therapy, 24, 1-8.
57.
Roy-Byrne, P. P., & Katon, W. (1997). Generalized anxiety disorder in primary care: The precursor/modifier pathway to increased health care utilisation. Journal of Clinical Psychiatry, 58(Suppl. 3), 34-40.
58.
Sanderson,W. C., Di Nardo,P. A., Rapee, R. M., & Barlow, D. H. (1990). Syndromecomorbidity in patients diagnosed with a DSM-III-R anxiety disorder. Journal of Abnormal Psychology, 99, 308-312.
59.
Sanderson,W. C., & Wetzler, S. (1991). Chronicanxietyandgeneralizedanxietydisorder:Issues in comorbidity. In R. M. Rapee & D. H. Barlow (Eds.), Chronic anxiety: Generalized anxiety disorder and mixed anxiety-depression (pp. 119-135). New York: Guilford.
60.
Schweizer, E., & Rickels, K. (1996). The long term management of GAD: Issues and dilemmas. Journal of Clinical Psychiatry, 57(Suppl. 7), 9-12.
61.
Souêtre, E., Lozet, H., Cimarosti, I., Martin, P., Chignon, J. M., Adès, J., et al. (1994). Cost of anxiety disorders: Impact of comorbidity. Journal of Psychosomatic Research, 38(Suppl. 1), 151-160.
62.
Spielberger, C. D. (1983). Manual for the State-Trait Anxiety Inventory (Form Y). Palo Alto, CA: Consulting Psychologists Press.
63.
Starcevic,V., Uhlenhuth,E. H., Kellner, R., & Patack,D. (1992). Patternsofcomorbidityin panic disorder and agoraphobia. Psychiatry Research, 42, 171-183.
64.
Steketee, G., Henninger, N. J., & Pollard, C. A. (2000). Predicting treatment outcomes for obsessive-compulsive disorder: Effects of comorbidity. In W. K. Goodman & M. V. Rudorfer (Eds.), Obsessive-compulsive disorder: Contemporary issues in treatment (personality and clinical psychology series) (pp. 257-274). Mahwah, NJ: Lawrence Erlbaum.
65.
Stephenson, R., Marchand, A., & Lavallée, M. C. (1997). Validation de l'Inventaire de mobilité pour l'agoraphobie auprès de la population québécoise francophone [Validation of Mobility Inventory for Agoraphobia in the Francophone population in Québec]. Science et Comportement, 26, 1-22.
66.
Stephenson,R., Marchand,A., & Lavallée, M. C. (1998). Validation du Questionnaire des sensations physiques auprès de la population canadienne-française[Validation of the Body Sensations Questionnaire in a French-Canadian population]. L'Encéphale, 24, 415-425.
67.
Stephenson, R., Marchand, A., & Lavallée, M. C. (1999). French-Canadian adaptation of the Agoraphobic Cognitions Questionnaire: Cross-cultural validation and gender differences. Scandinavian Journal of Behavior Therapy, 28, 58-69.
68.
Swinson, R. P., Cox, B. J., Kerr, S. A., Kuch, K., & Fergus, K. D. (1992). A survey of anxiety disorders clinics in Canadian hospitals. Canadian Journal of Psychiatry, 37, 188-191.
69.
Tsao, J. C. I., Lewin, M. R., & Craske, M. G. (1998). The effects of cognitive-behavior therapy for panic disorder on comorbid conditions. Journal of Anxiety Disorders, 12, 357-371.
70.
Turgeon, L., O'Connor, K. P., Marchand, A., & Freeston, M. H. (2002). Recollections of parentchild relationships in patients with obsessive-compulsive disorder and panic disorder with agoraphobia. Acta Psychiatrica Scandinavica, 105, 310-316.
71.
Wetzler, S., & Sanderson, W. C. (1995). Comorbidity of panic disorder. In G. M. Asnis & H. M. van Praag (Eds.), Panic disorder: Clinical, biological, and treatment aspects (pp. 80-98). New York: John Wiley.
72.
White, K. S., & Barlow, D. H. (2002). Panic disorder and agoraphobia. In D. H. Barlow (Ed.), Anxiety and its disorders: The nature and treatment of anxiety and panic (2nd ed., pp. 328-379). New York: Guilford.
73.
Wittchen, H. U., Carter, R. M., Pfister, H., Montgomery, S. A., & Kessler, R. C. (2000). Disabilities and quality of life in pure and comorbid generalized anxiety disorder and major depression in a national survey. International Clinical Psychopharmacology, 15, 319-328.
74.
Wittchen, H. U., Zhao, S., Kessler, R. C., & Eaton, W. W. (1994). DSM-III-R generalized anxiety disorderin theNationalComorbiditySurvey. Archives of General Psychiatry, 51, 355-364.
